Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
33.36
0.08 (0.24%)
At close: Aug 15, 2025, 3:59 PM
33.38
0.06%
After-hours: Aug 15, 2025, 04:54 PM EDT
Kiniksa Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 529.33M | 481.17M | 423.24M | 384.1M | 338.93M | 301.77M | 270.26M | 248.75M | 280.84M | 236.34M | 220.18M | 177.04M | 90M | 70.73M | 38.54M | 19.8M | 7.7M | n/a |
Cost of Revenue | 119.87M | 91.3M | 61.18M | 150.17M | 127.15M | 106.38M | 81.88M | 69.35M | 54.51M | 37.86M | 35.04M | 24.68M | 15.88M | 13.32M | 9.98M | 6.12M | 3.35M | 883K |
Gross Profit | 409.45M | 389.86M | 362.06M | 233.93M | 211.78M | 195.39M | 188.38M | 179.4M | 226.32M | 198.48M | 185.14M | 152.37M | 74.12M | 57.41M | 28.56M | 13.68M | 4.36M | -883K |
Operating Income | 4.47M | -15.8M | -45.62M | -26.24M | -27.5M | -30.54M | -25.2M | -19.23M | 38.11M | 21.9M | 9.84M | -32.34M | -109.42M | -130.6M | -156.64M | -173.4M | -185.95M | -177.26M |
Interest Income | n/a | n/a | n/a | 2.37M | 4.8M | 6.71M | 8.54M | 6.97M | 4.86M | 3.05M | 1.25M | 536K | 219K | 122K | 97K | 50K | 94K | 354K |
Pretax Income | 14.26M | -6.31M | -36.15M | -16.72M | -18.02M | -21.56M | -16.65M | -12.26M | 42.97M | 24.95M | 11.03M | -31.87M | -109.27M | -130.55M | -156.54M | -173.35M | -185.86M | -176.91M |
Net Income | 4.79M | -16.95M | -43.19M | -9.07M | -10.23M | 8.65M | 14.08M | -6.69M | 231.26M | 196.3M | 183.36M | 142.57M | -112.07M | -133.65M | -157.92M | -175.25M | -188.54M | -184.45M |
Selling & General & Admin | 177.33M | 172.86M | 168.01M | 164.22M | 152.28M | 139.06M | 129.43M | 119.9M | 110.11M | 104.78M | 97.95M | 93.48M | 89.56M | 87.57M | 85.95M | 78.71M | 69.75M | 57.44M |
Research & Development | 99.35M | 104.5M | 111.35M | 95.95M | 87M | 86.87M | 75.86M | 70.44M | 69.81M | 59.84M | 65.49M | 78.53M | 81.28M | 91.43M | 99.3M | 109.26M | 121.44M | 119.82M |
Other Expenses | 199.33M | 128.31M | 128.31M | n/a | n/a | n/a | 8.29M | 8.29M | 8.29M | 11.96M | 11.93M | 12.76M | 12.76M | 9.09M | 835K | n/a | n/a | n/a |
Operating Expenses | 476.01M | 405.67M | 407.67M | 260.17M | 239.28M | 225.93M | 213.58M | 198.63M | 188.21M | 176.58M | 175.37M | 184.77M | 183.6M | 188.09M | 186.08M | 187.97M | 191.19M | 177.26M |
Interest Expense | n/a | n/a | n/a | 1.83M | 1.83M | 1.83M | 1.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 388.22M | 496.97M | 468.86M | 410.33M | 366.44M | 332.31M | 295.45M | 267.98M | 242.73M | 214.44M | 210.41M | 209.45M | 199.49M | 201.41M | 195.18M | 193.2M | 193.66M | 177.26M |
Income Tax Expense | -618K | 10.64M | 7.04M | -7.66M | -7.79M | -30.21M | -30.74M | -5.57M | -188.28M | -171.36M | -172.34M | -174.44M | 2.8M | 3.1M | 1.39M | 1.9M | 2.68M | 7.54M |
Shares Outstanding (Basic) | 73.44M | 72.65M | 72.32M | 71.73M | 71M | 70.63M | 70.37M | 70.19M | 69.92M | 69.75M | 69.61M | 69.45M | 68.9M | 69.14M | 68.97M | 68.66M | 68.14M | 68.27M |
Shares Outstanding (Diluted) | 77.94M | 76.15M | 72.32M | 71.73M | 71M | 70.63M | 72.66M | 70.19M | 71.63M | 69.75M | 71.37M | 70.55M | 69.29M | 69.14M | 68.97M | 68.66M | 68.4M | 68.27M |
EPS (Basic) | 0.06 | -0.23 | -0.6 | -0.12 | -0.15 | 0.12 | 0.19 | -0.11 | 3.32 | 2.82 | 2.64 | 2.05 | -1.62 | -1.94 | -2.3 | -2.56 | -2.78 | -2.82 |
EPS (Diluted) | 0.04 | -0.24 | -0.6 | -0.13 | -0.16 | 0.11 | 0.18 | -0.11 | 3.27 | 2.77 | 2.59 | 2.00 | -1.62 | -1.94 | -2.3 | -2.56 | -2.78 | -2.82 |
EBITDA | 5.62M | -14.23M | -43.92M | -24.7M | -25.77M | -28.64M | -23.16M | -15.55M | 41.18M | 25.02M | 12.96M | -30.43M | -106.85M | -127.97M | -154.28M | -171.15M | -183.71M | -175.14M |
EBIT | 7.19M | -15.8M | -45.62M | -23.87M | -25.14M | -28.17M | -22.83M | -18.44M | 39.23M | 23.01M | 10.89M | -32.08M | -109.48M | -130.67M | -156.64M | -173.4M | -185.95M | -177.26M |
Depreciation & Amortization | 1.14M | 1.57M | 1.7M | 1.53M | 2.13M | 2.76M | 3.43M | 4.27M | 4.22M | 4.26M | 4.22M | 4.25M | 4.38M | 4.3M | 4.09M | 3.54M | 3.12M | 2.69M |